CD38-targeted immunopet of myeloma: phase 2 trial of clinical applications

Ended Project Grant Awarded Last action

Award ID
R01CA248398
Recipient
Awarding agency
Obligated
$2,709,106

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $560,238 $0
Amendment $50,000 $0
Amendment $50,000 $0
Amendment $577,160 $0
Amendment $577,160 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $40,000 $0
Amendment $40,000 $0
Amendment $40,000 $0
Amendment $40,000 $0
Amendment $0 $0
Amendment $0 $0
Amendment -$135,622 $0
Amendment $135,622 $0
Amendment -$135,622 -$135,622
Amendment $135,622 $135,622
Amendment $0 $0
Amendment $0 $0
Amendment $598,926 $0
Amendment -$598,926 $0
Amendment -$598,926 -$598,926
Amendment $598,926 $598,926
Original award $734,548 $0
Show all 26

Quick answers

Who received award R01CA248398?

R01CA248398 was awarded to Hoag Memorial Hospital Presbyterian by National Cancer Institute (National Institutes of Health) on July 1, 2020.

How much is award R01CA248398 worth?

$2,709,106 has been obligated on R01CA248398.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award